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CORRESPONDENCE
Privacy rights of human research 
participants in South Africa must be 
taken seriously
To the Editor: The Protection of Personal Information Act 4 of 
2013[1] (POPIA) was enacted by the South African (SA) parliament 
in 2013 after a long process of public consultation. To allow all sectors 
of SA society sufficient time to prepare to be compliant with POPIA, 
the SA government deferred the entering into force of the substantive 
provisions of POPIA for several years. Throughout this hiatus period, 
POPIA was widely publicised in the SA media, as is evident from any 
internet search.
POPIA requires – in no uncertain terms – that consent by a research 
participant must be for a specific, explicitly defined research project, 
rendering so-called broad consent insufficient. However, of late, this 
core provision of POPIA appears to be causing concern for some 
with relation to its application to genomic research in SA. On 4 and 
5 February 2019, a workshop was held in Cape Town on the topic of 
‘The governance of data sharing for genomic and other health-related 
data in Africa’. According to a report on this workshop in Science,[2] 
under the alarmist title ‘South African law may impede human 
health research’, some workshop attendees make the astonishing 
claim that they only discovered the specific consent provision of 
POPIA as recently as 2018 – a full 5 years after the enactment of the 
Act. If the report in Science is an accurate reflection of the mood of 
the workshop, instead of making expedited plans for compliance 
readiness, the workshop attendees rather contemplated plans of how 
to avoid compliance with POPIA’s core provision of specific consent. 
The plans that were contemplated included requesting exemptions 
from the Information Regulator and even having POPIA amended by 
Parliament. 
The most novel and extraordinary plan that emanated from the 
workshop was the idea that POPIA can be ‘interpreted’ to only require 
broad consent – not the higher benchmark of specific consent. This 
idea, expounded by Staunton et al.[3] in an article published in this 
journal, is purportedly based on the legal doctrine of purposive 
interpretation. We have serious reservations about the legal merits of 
Staunton et al.’s argument, which we set out in the article above.[4] 
Responsible scientists take the privacy rights of human research 
participants seriously. In the coming era of POPIA, this would 
require adoption of specific consent. We call on the SA scientific 
community to embrace this new legal requirement, as it shows 
respect for the autonomy and privacy rights of research participants. 
In this compliance-orientated paradigm, it would be worthwhile 
considering the use of dynamic consent models that use technology 
(such as cellphones) to facilitate specific consent and, more generally, to 
facilitate regular communication between research teams and research 
participants. 
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Staunton et al. respond: The Protection of Personal Information 
Act No. 4 of 2013 (POPIA)[1] is due to come into force on 1 April 
2020, but there is some uncertainty as to its practical implications 
with regard to the use of health data for research. In particular, our 
recent article on the legal status of broad consent under POPIA,[2] and 
Thaldar and Townsend’s response,[3] demonstrate that there is debate 
as to the legal status of broad consent under the terms of POPIA 
within the academic and scientific communities. 
In our article, we argue that the legal status of broad consent under 
POPIA will have a considerable impact on the sharing of health 
data for research in SA. However, the premise of our position is not 
that specific consent would undermine research in SA, as stated by 
Thaldar and Townsend. Indeed, specific consent is a long-established 
legal basis for processing personal information in many countries 
around the world, and we acknowledge and value this legal position. 
However, specific consent is not the only model for responsible 
research, and our argument is that broad consent for further 
processing of health data (which include genomic data) for scientific 
research purposes is legally permitted in terms of POPIA. 
Section 13(1) of POPIA requires personal information to be 
collected for a ‘specific, explicitly defined and lawful purpose’. Read in 
isolation, this would appear to permit specific consent only. However, 
in response to Thaldar and Townsend’s argument[3] that there ‘is 
nothing in the context of POPIA as a whole that suggests that section 
13(1) can refer to anything but a specific research study’, we posit 
that broad consent is permissible. Section 15(3)(e) permits further 
processing of personal information if it is to be used for research 
and the personal information will not be published in an identifiable 
form. POPIA therefore appears to require specific consent, but then 
states that further use of the personal information is not incompatible 
with the original purpose for which it was collected if it is used for 
research purposes. There is no indication that another, fresh consent 
from the data subject must be obtained prior to this further use. 
This implies that broad consent, i.e. a consent from the research 
participant at the point of collection that allows for future processing 
for scientific research, is legally permitted. 
Sections 13(1) and 15(3)(e) might appear to be in conflict. We 
argue, however, that a purposive interpretation of POPIA as a whole 
provides guidance and provides a coherent, consistent reading of the 
statute: POPIA makes it clear that the constitutional right to privacy 
is not absolute and may be subject to limitations ‘that are aimed 
at protecting other rights and important interests’, and section 2 
specifically states that these important interests include ‘the free flow 
of information within the Republic and across national borders’. We 
therefore agree with Thaldar and Townsend that a study that recruits 
research participants for specific consent and simultaneously requests 
broad consent for future research is legally permitted under POPIA. In 
addition, we described in our article that a purposive interpretation of 
POPIA makes it clear that broad consent alone would also be legally 
permitted under POPIA. The purpose of the workshop in February 
2020 was to discuss the legal challenges facing the sharing of health 
data for research in Africa. As reported in Science,[4] the uncertainty 
surrounding the legal status of broad consent under POPIA was 
highlighted to the scientific community in advance of the workshop. 
During the workshop, discussion centered on the sharing of data 
for genomic research in a manner that is compliant with ethical 
guidelines and good international practice, as well as POPIA and 
other SA regulatory frameworks. On this point it is worth noting 
that the General Data Protection Regulation similarly requires ‘freely 
given, specific, informed’ consent, but the European Data Protection 
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Supervisor recently stated that broad consent can be permitted ‘in the 
case of special categories of data on which much scientific research 
relies’. [4] In such cases the data controller will be expected to do more 
to ensure that ‘the essence of the data subject rights to valid consent 
are served, including through as much transparency as possible and 
other safeguards’.
Discussions on appropriate consent models for genomic research are 
ongoing and we welcome debate on the strengths and weaknesses of, as 
well as legal bases for, specific consent, tiered consent, broad consent 
and dynamic consent. This debate is urgent and essential in providing 
clarity for a variety of stakeholders, including the scientific community 
and research participants. The discussions so far in the SAMJ on the 
legal status of broad consent are a crucial part of this debate, but they 
form only one part. The issues raised to date point to the need for much 
wider engagement on this matter, including by the general public and 
the academic community. With the coming into force of POPIA, clarity 
on the legal status of broad consent under the Act is essential. As such, 
we call on the Information Regulator to exercise its power to consult 
in terms of section 40(1)(c), to engage with stakeholders on this matter 
and to issue a Code of Conduct as per section 40(1)(f) that clarifies 
matters, including the legal status of broad consent under POPIA.
Ciara Staunton
School of Law, Middlesex University, UK; and Institute for 
Biomedicine, Eurac Research, Italy
c.staunton@mdx.ac.uk
Rachel Adams
Human Sciences Research Council, Pretoria, South Africa; and 
Information Law and Policy Centre, Institute of Advanced Legal 
Studies, University of London, UK
M Botes
Biolawgic (Pty) Ltd, Johannesburg, South Africa
Edward S Dove
School of Law, University of Edinburgh, Scotland
Lyn Horn
Office of Research Integrity, University of Cape Town, South Africa
Melodie Labuschaigne
Department of Jurisprudence, School of Law, University of South 
Africa, Pretoria, South Africa
Glaudina Loots
Department of Science and Technology, Pretoria, South Africa
Safia Mahomed
Department of Jurisprudence, School of Law, University of South 
Africa, Pretoria, South Africa
Antonel Olckers
DNAbiotec (Pty) Ltd, Pretoria, South Africa
Michael S Pepper
Department of Immunology and Institute for Cellular and  
Molecular Medicine, Faculty of Health Sciences, University of  
Pretoria, South Africa
Anne Pope
Department of Private Law, Faculty of Law, University of Cape Town, 
South Africa
Michele Ramsay
Sydney Brenner Institute for Molecular Bioscience, Faculty of Health 
Sciences, University of the Witwatersrand, Johannesburg, South Africa 
Nora Ni Loideain
Information Law and Policy Centre, Institute of Advanced Legal 
Studies, University of London, UK
Jantina de Vries
Department of Medicine, Faculty of Health Sciences, University of 
Cape Town, South Africa
1. South Africa. Protection of Personal Information Act 4 of 2013. https://www.justice.gov.za/inforeg/
docs/InfoRegSA-POPIA-act2013-004.pdf (accessed 4 February 2020).
2. Staunton C, Adams R, Botes M, et al. Safeguarding the future of genomic research in South 
Africa: Broad consent and the Protection of Personal Information Act No. 4 of 2013. S Afr Med J 
2019;109(7):468-470. https://doi.org/10.7196/SAMJ.2019.v109i7.14148
3. Thaldar D, Townsend B. Genomic research and privacy: A response to Staunton et al. S Afr Med J 
2020;110(3):172-174. https://doi.org/10.7196/SAMJ.2020.v110i3.14431
4. Nordling L. South African law may impede human health research. Science 2019;363(6429):802. 
https://doi.org/10.1126/science.363.6429.802
5. European Data Protection Supervisor. A preliminary opinion on data protection and scientific 
research. 6 January 2020. https://edps.europa.eu/sites/edp/files/publication/20-01-06_opinion_
research_en.pdf (accessed 4 February 2020).
S Afr Med J 2020;110(3):175-176. https://doi.org/10.7196/SAMJ.2020.v110i3.14450
